139 related articles for article (PubMed ID: 38551804)
1. Inhibition of the glucocorticoid-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 drives concurrent 11-oxygenated androgen excess.
Schiffer L; Oestlund I; Snoep JL; Gilligan LC; Taylor AE; Sinclair AJ; Singhal R; Freeman A; Ajjan R; Tiganescu A; Arlt W; Storbeck KH
FASEB J; 2024 Apr; 38(7):e23574. PubMed ID: 38551804
[TBL] [Abstract][Full Text] [Related]
2. The glucocorticoid-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 catalyzes the activation of testosterone.
Oestlund I; Snoep J; Schiffer L; Wabitsch M; Arlt W; Storbeck KH
J Steroid Biochem Mol Biol; 2024 Feb; 236():106436. PubMed ID: 38035948
[TBL] [Abstract][Full Text] [Related]
3. Conversion of Classical and 11-Oxygenated Androgens by Insulin-Induced AKR1C3 in a Model of Human PCOS Adipocytes.
Paulukinas RD; Mesaros CA; Penning TM
Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35560164
[TBL] [Abstract][Full Text] [Related]
4. 11-Oxygenated androgen precursors are the preferred substrates for aldo-keto reductase 1C3 (AKR1C3): Implications for castration resistant prostate cancer.
Barnard M; Quanson JL; Mostaghel E; Pretorius E; Snoep JL; Storbeck KH
J Steroid Biochem Mol Biol; 2018 Oct; 183():192-201. PubMed ID: 29936123
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood mononuclear cells preferentially activate 11-oxygenated androgens.
Schiffer L; Bossey A; Kempegowda P; Taylor AE; Akerman I; Scheel-Toellner D; Storbeck KH; Arlt W
Eur J Endocrinol; 2021 Mar; 184(3):353-363. PubMed ID: 33444228
[TBL] [Abstract][Full Text] [Related]
6. Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis.
Blouin K; Nadeau M; Mailloux J; Daris M; Lebel S; Luu-The V; Tchernof A
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E244-55. PubMed ID: 18984855
[TBL] [Abstract][Full Text] [Related]
7. AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome.
O'Reilly MW; Kempegowda P; Walsh M; Taylor AE; Manolopoulos KN; Allwood JW; Semple RK; Hebenstreit D; Dunn WB; Tomlinson JW; Arlt W
J Clin Endocrinol Metab; 2017 Sep; 102(9):3327-3339. PubMed ID: 28645211
[TBL] [Abstract][Full Text] [Related]
8. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
Pereira CD; Azevedo I; Monteiro R; Martins MJ
Diabetes Obes Metab; 2012 Oct; 14(10):869-81. PubMed ID: 22321826
[TBL] [Abstract][Full Text] [Related]
9. Absence of 11-keto reduction of cortisone and 11-ketotestosterone in the model organism zebrafish.
Tsachaki M; Meyer A; Weger B; Kratschmar DV; Tokarz J; Adamski J; Belting HG; Affolter M; Dickmeis T; Odermatt A
J Endocrinol; 2017 Feb; 232(2):323-335. PubMed ID: 27927697
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride.
Byrns MC; Mindnich R; Duan L; Penning TM
J Steroid Biochem Mol Biol; 2012 May; 130(1-2):7-15. PubMed ID: 22265960
[TBL] [Abstract][Full Text] [Related]
11. 11β-hydroxysteroid dehydrogenase-1 deficiency alters brain energy metabolism in acute systemic inflammation.
Verma M; Kipari TMJ; Zhang Z; Man TY; Forster T; Homer NZM; Seckl JR; Holmes MC; Chapman KE
Brain Behav Immun; 2018 Mar; 69():223-234. PubMed ID: 29162555
[TBL] [Abstract][Full Text] [Related]
12. Understanding the Role of Androgen Action in Female Adipose Tissue.
Schiffer L; Arlt W; O'Reilly MW
Front Horm Res; 2019; 53():33-49. PubMed ID: 31499495
[TBL] [Abstract][Full Text] [Related]
13. Androgen metabolism in adipose tissue: recent advances.
Blouin K; Veilleux A; Luu-The V; Tchernof A
Mol Cell Endocrinol; 2009 Mar; 301(1-2):97-103. PubMed ID: 19022338
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
Masuzaki H; Flier JS
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid and androgen signaling pathways diverge between advertisement calling and non-calling fish.
Genova RM; Marchaterre MA; Knapp R; Fergus D; Bass AH
Horm Behav; 2012 Sep; 62(4):426-32. PubMed ID: 22884426
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-induced androgen inactivation by aldo-keto reductase 1C2 promotes adipogenesis in human preadipocytes.
Veilleux A; Côté JA; Blouin K; Nadeau M; Pelletier M; Marceau P; Laberge PY; Luu-The V; Tchernof A
Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E941-9. PubMed ID: 22275760
[TBL] [Abstract][Full Text] [Related]
17. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
Walker BR
Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
[TBL] [Abstract][Full Text] [Related]
18. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC
du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC
J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls.
Gambineri A; Fanelli F; Tomassoni F; Munarini A; Pagotto U; Andrew R; Walker BR; Pasquali R
Eur J Endocrinol; 2014 Jul; 171(1):47-57. PubMed ID: 24743397
[TBL] [Abstract][Full Text] [Related]
20. Human dehydrogenase/reductase SDR family member 11 (DHRS11) and aldo-keto reductase 1C isoforms in comparison: Substrate and reaction specificity in the reduction of 11-keto-C
Endo S; Morikawa Y; Kudo Y; Suenami K; Matsunaga T; Ikari A; Hara A
J Steroid Biochem Mol Biol; 2020 May; 199():105586. PubMed ID: 31926269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]